American Tony completes reverse merger with Aim Smart

Under the terms of the merger agreement, the former American Tony shareholders exchanged their shares for Aim Smart shares so that, upon the closing of the merger, the former American Tony shareholders own 96.7% of the outstanding shares of Aim Smart. Aim Smart intends to change its name to American Tony Pharmaceutical and apply for a new trading symbol in the near future.

Mingli Yao, founder and CEO of American Tony, said: “American Tony is a rapidly growing pharmaceutical company. We offer unique traditional Chinese medicines combined with elements of Western medicine, and market our products throughout China.

“We are pleased to be taking the next step in American Tony’s history, by becoming a publicly traded company. We look forward to rewarding our shareholders with opportunities associated with our vision of becoming one of the largest pharmaceutical companies in China through acquisitions and organic growth.”